Robert I. Grossman, MD
Saul J. Farber Dean and Chief Executive Officer
Robert I. Grossman, MD, was named Saul J. Farber Dean and chief executive officer of NYU Langone Health in July 2007. NYU Langone comprises more than 330 locations throughout the New York area and 6 inpatient locations, including Tisch Hospital, Kimmel Pavilion, NYU Langone Orthopedic Hospital, Hassenfeld Children’s Hospital at NYU Langone, NYU Langone Hospital—Brooklyn, and Rusk Rehabilitation. NYU Langone recently established a partnership with Winthrop-University Hospital, now known as NYU Winthrop Hospital—one of Long Island’s top medical centers. Also part of NYU Langone are Perlmutter Cancer Center, a National Cancer Institute–designated cancer center, and NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history.
Early in his tenure, Dr. Grossman launched a major campus transformation that has resulted in the addition of more than 7 million square feet of clinical, educational, and research space. This includes the 365,000-square-foot Science Building, which opened in January 2018, and the 830,000-square-foot Kimmel Pavilion, which includes Hassenfeld Children’s Hospital and opened in June 2018.
In collaboration with the Board of Trustees and institutional leadership, Dr. Grossman has increased NYU Langone’s revenue by more than $7 billion and has raised more than $2.7 billion in philanthropy. In addition, NYU Langone’s National Institutes of Health (NIH) 2017 research awards totaled $451 million—an increase of more than 250 percent since 2007.
Long recognized as one of the best hospitals in the country, NYU Langone has been ranked by U.S. News & World Report as one of the top 20 hospitals nationwide. In 2016, Modern Healthcare’s Top 100 Hospitals annual survey placed NYU Langone No. 7 among the top 15 major teaching hospitals. A New York City hospital has never made the Top 100 before, and it is the first time in 15 years that a New York State hospital has been represented on the list.
NYU Langone is among just 9 percent of hospitals nationwide to earn a 5-star rating for safety, quality, and patient experience from the Center for Medicare and Medicaid Services. NYU Langone is the only full-service hospital in the state of New York to earn this distinction. Additionally, for the past several years, NYU Langone has received top rankings for overall patient safety and quality of care from Vizient, Inc., formerly the University HealthSystem Consortium. In 2017, NYU Langone received two significant awards from Vizient: the Bernard A. Birnbaum, MD, Quality Leadership Award and the Ambulatory Care Quality and Accountability Award for demonstrated excellence in delivering high-quality, patient-centered outpatient care.
As dean of NYU School of Medicine, he presided over the announcement of tuition-free medical education for all current and future students in its MD degree program. Dr. Grossman also curated a new approach to medical education, called Curriculum for the 21st Century (C21). It emphasizes clinical training from the beginning of medical school and includes a revolutionary three-year MD program for select candidates. On U.S. News & World Report’s 2019 Best Graduate Schools list, NYU School of Medicine ranked No. 3 nationally among research-intensive schools of medicine and No. 1 in New York.
Dr. Grossman joined NYU Langone in 2001 as the Louis Marx Professor of Radiology, chairman of the Department of Radiology, and professor of neurology, neurosurgery, and physiology and neuroscience. In his previous position at the Hospital of the University of Pennsylvania, he was a professor of radiology, neurosurgery, and neurology; chief of neuroradiology; and associate chairman of radiology.
A prolific and highly respected scientist, Dr. Grossman was awarded the Javits Neuroscience Investigator Award by the NIH in 1999 for his work on multiple sclerosis. He was a member (1995–2000) and chairman (1997–2000) of the Diagnostic Radiology Study Section at the NIH, was appointed to the NIH’s National Advisory Council for Biomedical Imaging and Bioengineering (2003–2007), and, in 2004, became the first recipient of the Outstanding Contributions in Research Award, given annually by the Foundation of the American Society of Neuroradiology in recognition of lifelong accomplishment and consistent excellence in clinical neuroscience. In 2010, he received the International Society for Magnetic Resonance in Medicine’s (ISMRM’s) Gold Medal for his pioneering research in magnetic resonance in medicine and biology. In addition, he was named a Distinguished Graduate of the University of Pennsylvania School of Medicine and was awarded an honorary doctorate from the University of Bordeaux, France.
In 2018, Dr. Grossman was named to Time magazine’s inaugural Health Care 50 list of the 50 most influential healthcare leaders who changed the state of healthcare in America, together with Ken Langone, chairman of NYU Langone’s Board of Trustees. Additionally, Dr. Grossman was named a “Living Landmark” by the New York Landmarks Conservancy in 2013 for his leadership in the aftermath of Hurricane Sandy, which caused unprecedented damage to NYU Langone’s facilities and required the safe evacuation of 322 patients.
Dr. Grossman is a passionate educator and widely published scholar. He has trained more than 100 fellows, many of whom occupy prominent positions worldwide, and has authored 338 publications and 5 books, including Neuroradiology: The Requisites.
Dr. Grossman received his BS in biology, Phi Beta Kappa, from Tulane University and his MD from the University of Pennsylvania, where he was elected to Alpha Omega Alpha. He completed his internship at Beth Israel Hospital in Boston, two years of a neurosurgery residency at the University of Pennsylvania, a radiology residency at the University of Pennsylvania, and a two-year fellowship in neuroradiology at Massachusetts General Hospital. Dr. Grossman is board certified in radiology and neuroradiology.